[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @HothInc Hoth Therapeutics, Inc. Hoth Therapeutics, Inc. posts on X about nasdaq, $hoth, vienna, austria the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1050398617280933888/interactions)  - X Week XXX -XX% - X Month XXXXX +2,238% ### Mentions: X [#](/creator/twitter::1050398617280933888/posts_active)  - X Week X +17% - X Month XX +1,400% ### Followers: XXX [#](/creator/twitter::1050398617280933888/followers)  - X Week XXX +3% ### CreatorRank: undefined [#](/creator/twitter::1050398617280933888/influencer_rank)  ### Social Influence [#](/creator/twitter::1050398617280933888/influence) --- **Social category influence** [exchanges](/list/exchanges) XXX% [travel destinations](/list/travel-destinations) XXXXX% [countries](/list/countries) XXXXX% [stocks](/list/stocks) XXXXX% [technology brands](/list/technology-brands) XXXXX% **Social topic influence** [nasdaq](/topic/nasdaq) #786, [$hoth](/topic/$hoth) #4, [vienna](/topic/vienna) 14.29%, [austria](/topic/austria) 14.29%, [potent](/topic/potent) 14.29%, [applications](/topic/applications) 14.29%, [more info](/topic/more-info) XXXXX% **Top accounts mentioned or mentioned by** [@wc25b](/creator/undefined) [@rarediseaseadv](/creator/undefined) [@stocks2watch_](/creator/undefined) ### Top Social Posts [#](/creator/twitter::1050398617280933888/posts) --- Top posts by engagements in the last XX hours "Hoth Therapeutics has expanded its intellectual property portfolio for HT-001 a topical therapeutic for chemotherapy-induced rash. Hear more from our CEO Robb Knie. 🎬: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1975198388724379784) [@HothInc](/creator/x/HothInc) 2025-10-06T13:56Z XXX followers, XXX engagements "CEO Robb Knie will be presenting at the upcoming BIO-Europe 2025 Conference taking place November XX 2025 in Vienna Austria. Mr. Knie will highlight Hoth's two leading development programs: HT-001 & HT-KIT Read: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1975577205880033682) [@HothInc](/creator/x/HothInc) 2025-10-07T15:01Z XXX followers, XXX engagements "Hoth Therapeutics has expanded its AI initiative through a new NVIDIA AI Enterprise subscription license to accelerate data-driven drug development preclinical modeling and predictive analytics. Read more: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1975946033403216162) [@HothInc](/creator/x/HothInc) 2025-10-08T15:27Z XXX followers, XXX engagements "Were proud to share that preclinical results highlighting the potent antitumor effects of HT-KIT our promising cancer drug are featured by @RareDisease_Adv. Read more: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1978445788549099764) [@HothInc](/creator/x/HothInc) 2025-10-15T13:00Z XXX followers, XX engagements "Our HT-001 drug is being developed to address skin side effects from cancer treatments strengthening Hoths position in oncology support care. Continue reading: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1978476014243102766) [@HothInc](/creator/x/HothInc) 2025-10-15T15:00Z XXX followers, XX engagements "The new patent applications demonstrate Hoth's commitment to unlocking the full therapeutic potential of HT-001 across multiple high-value indications. For more info visit: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1978808243905241259) [@HothInc](/creator/x/HothInc) 2025-10-16T13:00Z XXX followers, XX engagements "We believe biotech must go beyond drug development and marketing. Were committed to delivering therapies that truly address the needs of patients and their families. 🩺 Read: NASDAQ: $HOTH" [X Link](https://x.com/HothInc/status/1979170547998072949) [@HothInc](/creator/x/HothInc) 2025-10-17T13:00Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@HothInc Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. posts on X about nasdaq, $hoth, vienna, austria the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX -XX%
- X Month XXXXX +2,238%
Mentions: X #
- X Week X +17%
- X Month XX +1,400%
Followers: XXX #
- X Week XXX +3%
CreatorRank: undefined #
Social Influence #
Social category influence exchanges XXX% travel destinations XXXXX% countries XXXXX% stocks XXXXX% technology brands XXXXX%
Social topic influence nasdaq #786, $hoth #4, vienna 14.29%, austria 14.29%, potent 14.29%, applications 14.29%, more info XXXXX%
Top accounts mentioned or mentioned by @wc25b @rarediseaseadv @stocks2watch_
Top Social Posts #
Top posts by engagements in the last XX hours
"Hoth Therapeutics has expanded its intellectual property portfolio for HT-001 a topical therapeutic for chemotherapy-induced rash. Hear more from our CEO Robb Knie. 🎬: NASDAQ: $HOTH"
X Link @HothInc 2025-10-06T13:56Z XXX followers, XXX engagements
"CEO Robb Knie will be presenting at the upcoming BIO-Europe 2025 Conference taking place November XX 2025 in Vienna Austria. Mr. Knie will highlight Hoth's two leading development programs: HT-001 & HT-KIT Read: NASDAQ: $HOTH"
X Link @HothInc 2025-10-07T15:01Z XXX followers, XXX engagements
"Hoth Therapeutics has expanded its AI initiative through a new NVIDIA AI Enterprise subscription license to accelerate data-driven drug development preclinical modeling and predictive analytics. Read more: NASDAQ: $HOTH"
X Link @HothInc 2025-10-08T15:27Z XXX followers, XXX engagements
"Were proud to share that preclinical results highlighting the potent antitumor effects of HT-KIT our promising cancer drug are featured by @RareDisease_Adv. Read more: NASDAQ: $HOTH"
X Link @HothInc 2025-10-15T13:00Z XXX followers, XX engagements
"Our HT-001 drug is being developed to address skin side effects from cancer treatments strengthening Hoths position in oncology support care. Continue reading: NASDAQ: $HOTH"
X Link @HothInc 2025-10-15T15:00Z XXX followers, XX engagements
"The new patent applications demonstrate Hoth's commitment to unlocking the full therapeutic potential of HT-001 across multiple high-value indications. For more info visit: NASDAQ: $HOTH"
X Link @HothInc 2025-10-16T13:00Z XXX followers, XX engagements
"We believe biotech must go beyond drug development and marketing. Were committed to delivering therapies that truly address the needs of patients and their families. 🩺 Read: NASDAQ: $HOTH"
X Link @HothInc 2025-10-17T13:00Z XXX followers, XX engagements